Xu NA, Haihong GUO, Jiao LI. Transfer of value from pharmaceutical industry to physicians in open government survey[J]. Big data research, 2017, 3(3): 2017034.
DOI:
Xu NA, Haihong GUO, Jiao LI. Transfer of value from pharmaceutical industry to physicians in open government survey[J]. Big data research, 2017, 3(3): 2017034. DOI: 10.11959/j.issn.2096-0271.2017034.
Transfer of value from pharmaceutical industry to physicians in open government survey
Potential conflicts of interest arising from the transfer of value between pharmaceutical industry and physicians could significantly affect clinical care
research findings and physician decision-making.To enhance the transparency of the transfer of value between pharmaceutical industry and physicians
the open payments program of USA and disclosure UK datasets from four aspects:data resources
open status
type of transfer of value and policy guarantee were introduced.In addition
the international research advances based on the datasets were also reviewed.At last
the characteristics and existing problems of the datasets were discussed.The inspiration for China was proposed.
关键词
Keywords
references
LO B , FIELD M J . Conflict of interest in medical research,education,and practice [M ] . Washington,DC : National Academies PressPress , 2009 .
SLAUGJTER M S , ROGERS J G , MILANO C A , et al . Advanced heart failure treated with continuous-flow left ventricular assist device [J ] . New England Journal of Medicine , 2009 , 361 ( 23 ): 2241 - 2251 .
CARLAT D . Exploring the link between industry payments to doctors and prescribing habits [J ] . BMJ , 2014 , 349 g6651.
CHANG J S . The physician payments sunshine act:data evaluation regarding payments to ophthalmologists [J ] . Ophthalmology , 2015 , 122 ( 4 ): 656 - 661 .
AHMED R , LOPEZ J , BAE S , et al . Where the sun shines:industry’s payments to plastic surgeons [J ] . Plastic and Reconstructive Surgery , 2015 , 136 ( 4 Suppl ): 58 .
ROHRICH R J . The process of publishing industry-affiliated articles in plastic and reconstructive surgery [J ] . Plastic and Reconstructive Surgery , 2014 , 133 ( 3 ): 757 - 760 .
LISTED N . Doctors and pharma in China [J ] . Lancet , 2013 , 382 ( 9887 ): 102 .
ROSS J S , LACKNER J E , LURIE P , et al . Pharmaceutical company payments to physicians:early experiences with disclosure laws in vermont and minnesota [J ] . JAMA , 2007 , 297 : 1216 - 1223 .
AGRAWAL S , BROWN D . The physician payments sunshine act--two years of the open payments program [J ] . New England Journal of Medicine , 2016 , 374 ( 10 ): 906 - 909 .
USGA Office . Medicare,Medicaid,children’s health insurance programs;transparency reports and reporting of physician ownership or investment interests [J ] . Federal Register , 2013 , 78 ( 27 ): 9457 .
ROSENTHAL M B , MELLO M M . Sunlight as disinfectant--new rules on disclosure of industry payments to physicians [J ] . New England Journal of Medicine , 2013 , 368 ( 22 ): 2052 - 2054 .
AGRAWAL S , BRENNAN N , BUDETTI P . The sunshine act--effects on physicians [J ] . New England Journal of Medicine , 2013 , 368 ( 22 ): 2054 - 2057 .
HAWKES N . Doctors getting biggest payments from drug companies don't declare them on new website [J ] . BMJ , 2016 , 354 :i3679.
PERLIS R H , PERLIS C S . Physician payments from industry are associated with greater medicare part D prescribing costs [J ] . Plos One , 2016 , 11 ( 5 ):e0155474.
LOPEZ J , AHMED R , BAE S , et al . A new culture of transparency:industry payments to orthopedic surgeons [J ] . Orthopedics , 2016 , 39 ( 6 ): e1058 - e1062 .
AHMED R , BAE S , HICKS C W , et al . Here comes the sunshine:industry’s payments to cardiothoracic surgeons [J ] . Annals of Thoracic Surgery , 2016 , 103 ( 2 ): 567 .
FLEISCHMAN W , AGRAWAL S , KING M , et al . Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing:cross sectional ecological study [J ] . BMJ , 2016 , 354 :i4189.
YEH J S , FRANKLIN J M , AVORN J , et al . Association of industry payments to physicians with the prescribing of brandname statins in massachusetts [J ] . Jama Internal Medicine , 2016 , 176 ( 6 ): 763 .
ADLINGTON K , GODLEE F . Disclosure UK:transparency should no longer be an optional extra [J ] . BMJ , 2016 , 354 : 3730 .